CS47
CS47 is a Thioredoxin Reductase 1 (TRXR1) inhibitor and ferroptosis inducer. CS47 binds non-covalently to sites between the FAD and NADPH pockets of TRXR1. CS47 drives glutathione depletion, lipid reactive oxygen species accumulation, HMOX1-dependent iron overload, and selective cytotoxicity in lung cancer cells. CS47 can be used for the research of lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 1372792-51-2
- Formula: C21H16AuCl2N2P
- Molecular Weight:595.21
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
CS47 (48 h) selectively reduces viability of KRAS-WT and EGFR-MUT human lung cancer cells in 2D culture with IC50 values of 6.74 µM and 6.78 µM, respectively, while showing much lower potency against KM lung cancer cells (IC50 = 24.22 µM) and normal IMR90 fibroblasts (IC50 = 54.85 µM)[1].
CS47 (48 h) induces potent cell death in 3D spheroids of KRAS-WT (H661, H522) and EGFR-MUT (HCC827) human lung cancer cells, but not in KM (H460) or KRAS-WT H522 cells with KM overexpression[1].
CS47 (2 μM; 24 h) induces significant lipid peroxidation in KRAS-WT human lung cancer cells (H1993, H1395), but not in KRASG12C human lung cancer cells (H157, A549)[1].
CS47 (2 μM; 24 h) alters lipid homeostasis in KRAS-WT H522 human lung cancer cells, inducing enrichment of ferroptosis-associated PUFA-containing phospholipids and accumulation of LPC and PUFA-containing TG[1].
CS47 (24 h) induces transcriptomic reprogramming in KRAS-WT and EGFR-MUT human lung cancer cells, downregulating lipid biosynthesis and selenoprotein genes while upregulating ferroptosis-related genes involved in antioxidant response, iron metabolism, and GSH homeostasis; HMOX1 is universally upregulated across all genotypes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
| Species | Dose | Route | Cmax | Tmax | T1/2 | AUClast | Vz/F | CL/F | MRT |
|---|---|---|---|---|---|---|---|---|---|
| Mice[1] | 10 mg/kg | i.p. | 20.33 μg/mL | 90 min | 3803 min | 23737567 min·ng/mL | 538 mL/kg | 0.098 mL/min/kg | 686 min |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NCG (Nod Scid IL-2Rγ-/-) mice (9 weeks) injected with H661 and H661-HMOX1 cells[1]
-
Dosage:3 mg/kg
-
Administration:i.p.; every 3 days; 25 days
-
Result:Produced a significant anti-tumor effect, with tumor volumes remaining far lower than vehicle controls throughout the 25-day treatment period.
Increased intratumoral C11-BODIPY oxidation, a marker of lipid peroxidation.
Induced accumulation of polyunsaturated fatty acid-containing phospholipids and triacylglycerols, consistent with ferroptosis.
Did not cause significant weight loss in mice.
Exhibited no marked leukopenia or neutropenia observed.
Exhibited even more pronounced anti-tumor effect in H661-HMOX1-GFPlo xenografts.
Increased intratumoral accumulation of 4-Hydroxynonenal, a marker of ferroptosis, in both parental and HMOX1-overexpressing xenografts.
Chemical Information
-
CAS No. 1372792-51-2
-
Molecular Weight 595.21
-
Formula C21H16AuCl2N2P
-
SMILES
ClC1=C(Cl)[N-]([Au+][P](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Perls' Prussian Blue Iron Staining
Perls' Prussian blue staining is a histochemical method used to detect non-heme ferric iron (Fe3+) in biological tissues by exploiting an acid-mediated release of loosely bound iron from storage complexes such as ferritin or hemosiderin, followed by its reaction with potassium ferrocyanide to form an insoluble blue ferric ferrocyanide (Prussian blue) precipitate that marks iron localization under light microscopy. The reaction is classically performed under acidic conditions, which liberate Fe3+ ions that subsequently bind ferrocyanide to generate the visible chromogen, enabling spatial visualization of iron deposits in tissues such as brain, liver, and spleen. Histochemical interpretations are limited to a reactive iron pool rather than total iron content, reflecting only histologically accessible iron species rather than tightly protein-bound iron.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)